2. Disease Areas
  3. Neurological, Eye or Ear Disease
  4. CNS Infection
  5. Prion Disease

Prion Disease

Prion diseases are rare, invariably fatal neurodegenerative disorders caused by the misfolding and accumulation of abnormal prion proteins in the brain, leading to rapid neuronal damage, spongiform degeneration, and progressive loss of cognitive and motor functions. These diseases, including sporadic, genetic, and acquired forms such as Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease, exhibit rapid progression, with symptoms emerging suddenly and worsening quickly over months to years. Prions propagate by inducing normal cellular proteins to adopt abnormal conformations, triggering a cascade of neurodegeneration. Transmission can occur through exposure to infected tissues, contaminated medical instruments, or consumption of prion-contaminated meat, particularly in the case of bovine spongiform encephalopathy-linked variants. Despite extensive research, no effective treatments or preventive measures are currently available, underscoring their terminal nature and significant clinical challenge.

References:

Prion Disease (1):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-153074
    ISR-IN-1 1628478-15-8 98.92%
    ISR-IN-1 is an integrated stress response (ISR) inhibitor targeting eIF2B. ISR-IN-1 enhances eIF2B guanine nucleotide exchange factor activity, stabilizes eIF2B heteropentamer dimers via symmetrical protein-protein interface binding, and releases global protein synthesis inhibition from phosphorylated eIF2αα. ISR-IN-1 can be used for the research of prion disease.
    ISR-IN-1